文献速递乳腺技术与安全PETCT

脾脏18F-氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描活性升高与非转移性乳腺浸润性导管癌5年复发风险相关

Elevated splenic 18F-fluorodeoxyglucose positron emission tomography/computed tomography activity is associated with 5-year risk of recurrence in non-metastatic invasive ductal carcinoma of the breast.
PubMed 文献 · Br J Radiol · 2024-01-01

本研究纳入101例连续女性乳腺浸润性导管癌患者,构建包含肿瘤病灶及非肿瘤淋巴组织基线18F-FDG PET/CT代谢参数的预测模型,用于预测影像检查后5年内无复发生存(5y-RFS)。多变量分析显示N3状态、肿瘤总代谢体积、脾脏最大标准化摄取值及脾肝比为5y-RFS的显著预测因子;包含所有显著预测因子的列线图预测性能最优,C指数为0.907(95% CI,0.833-0.981)。

要点

  • 脾脏最大标准化摄取值和脾肝比是乳腺浸润性导管癌5年复发的显著预测因子。
  • 包含脾脏代谢参数的列线图对5y-RFS预测性能最佳,C指数为0.907(95% CI,0.833-0.981)。
  • N3状态和肿瘤总代谢体积也是5y-RFS的显著预测因子。

核心结论

  • 包含脾脏代谢参数的模型对乳腺浸润性导管癌患者5y-RFS预测性能最佳,可能指导个体化治疗决策并向患者和临床医生提供预后信息。

研究设计与样本

  • 研究纳入101例连续女性乳腺浸润性导管癌患者,采用单变量和多变量Cox回归识别与复发风险相关的临床病理及代谢参数,基于多变量分析结果构建4个预测模型并绘制列线图,使用C指数、综合判别改善指数、决策曲线分析和校准曲线评估各列线图性能。

诊断标准与关键数值

  • N3状态、肿瘤总代谢体积、脾脏最大标准化摄取值和脾肝比为5y-RFS的显著预测因子;包含所有显著预测因子的列线图C指数为0.907(95% CI,0.833-0.981),决策曲线分析显示最大净获益,校准曲线准确性良好,Kaplan-Meier曲线风险分层优秀。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To construct prediction models including baseline 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) metabolic parameters of tumoural lesions and non-tumour lymphoid tissue for recurrence-free survival within 5 years (5y-RFS) after imaging examination in patients with invasive ductal carcinomas (IDCs) of the breast.

METHODS: The study included 101 consecutive female patients. Univariable and multivariable Cox regression were used to identify clinicopathological and metabolic parameters associated with risk of recurrence. Four prediction models based on the results of multivariable analysis were constructed and visualized as nomograms. Performance of each nomogram was evaluated using the concordance index (C-index), integrated discrimination improvement, decision curve analysis (DCA), and calibration curve.

RESULTS: N3 status, total metabolic tumour volume, the maximum standardized uptake value of spleen, and spleen-to-liver ratio were significant predictors of 5y-RFS. The nomogram including all significant predictors demonstrated superior predictive performance for 5y-RFS, with a C-index of 0.907 (95% CI, 0.833-0.981), greatest net benefit on DCA, good accuracy on calibration curves, and excellent risk stratification on Kaplan-Meier curves.

CONCLUSIONS: The model that included metabolic parameters of the spleen had the best performance for predicting 5y-RFS in patients with IDCs of the breast. This model may guide personalized treatment decisions and inform patients and clinicians about prognosis.

ADVANCES IN KNOWLEDGE: This research identifies 18F-FDG PET/CT metabolic parameters of non-tumour lymphoid tissue as predictors of recurrence in breast cancer.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Wang Y, Li Y, Jiang H, et al. Elevated splenic 18F-fluorodeoxyglucose positron emission tomography/computed tomography activity is associated with 5-year risk of recurrence in non-metastatic invasive ductal carcinoma of the breast. Br J Radiol. 2024. PMID: 38263821. doi:10.1093/bjr/tqad015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。